Skip to content
Home/Companies/Biotech/Centessa Pharmaceuticals
Centessa Pharmaceuticals

Centessa Pharmaceuticals

Biotech·US·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Centessa Pharmaceuticals?

Centessa Pharmaceuticals is currently owned by General Atlantic through General Atlantic (2020 vintage), since 2021. Across its history, Centessa Pharmaceuticals has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

General Atlantic
Most recent investor
General Atlantic
General Atlantic · 2020 · Growth
2 ownership periods · full history below

Key facts

HQUnited States
SectorBiotech

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by IP Group and General Atlantic since 2021.
Co-invest · 2 holders · 2021 · present
IP Group
IP GroupActive
2021 · present(5yr) · IP Group (Evergreen) · 2001 · Evergreen
General Atlantic
2021 · present(5yr) · General Atlantic · 2020 · Growth
Track Centessa Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Centessa Pharmaceuticals?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Centessa Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue